Active Research Protocols
- 05-N-0245 – A Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients with Friedreich's Ataxia
- 09-N-0197 – Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients with Primary Progressive Multiple Sclerosis
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014